Lombard Odier Asset Management (Switzerland)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$969K	Sell	3,220 -100	-3%	-$30.2K	0.03%	315
2026 Q1	$1.1M	Buy	+3,320	New	+$1.13M	0.04%	284
2023 Q2	–	Sell	-76,103	Closed	-$15.2M	–	154
2023 Q1	$15.2M	Buy	76,103 +19,365	+34%	+$4.07M	1.33%	20
2022 Q4	$13.5M	Buy	56,738 +21,125	+59%	+$4.51M	1.08%	34
2022 Q3	$7.13M	Sell	35,613 -10,491	-23%	-$2M	0.6%	49
2022 Q2	$6.72M	Sell	46,104 -36,934	-44%	-$5.24M	0.57%	43
2022 Q1	$13.6M	Buy	+83,038	New	+$12.7M	1.06%	37

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s ALNY Position: Q2 2026 in Review

Lombard Odier Asset Management (Switzerland) reduced its Alnylam Pharmaceuticals (ALNY) stake by 3% in Q2 2026, selling an estimated $30.2K and leaving 3,220 shares worth $969K. The position accounts for 0.03% of the portfolio, ranked #315.

Lombard Odier Asset Management (Switzerland) first reported a position in ALNY in Q1 2022 and has held it in 7 quarters since. The position peaked at $15.2M in Q1 2023. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Lombard Odier Asset Management (Switzerland) held 3,220 shares of Alnylam Pharmaceuticals worth $969K as of Q2 2026.
Lombard Odier Asset Management (Switzerland) sold 100 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $30.2K.
Alnylam Pharmaceuticals made up 0.03% of Lombard Odier Asset Management (Switzerland)'s portfolio in Q2 2026, its #315 holding.
Lombard Odier Asset Management (Switzerland) first reported a position in Alnylam Pharmaceuticals in Q1 2022 and has held it in 7 quarters since.
Lombard Odier Asset Management (Switzerland)'s Alnylam Pharmaceuticals position peaked at $15.2M in Q1 2023.
785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2026, filed 14 Aug 2026.